CRISPR Therapeutics, Vertex start first company-backed human CRISPR trialAllbiopro2018-09-05T09:40:48+09:009월 5th, 2018|
Radius Health hires oncology-focused CMO as it moves into breast cancer trialsAllbiopro2018-09-05T09:40:16+09:009월 5th, 2018|
EyeGate’s anti-inflammatory eye drug and electric delivery device fail phase 3 trialAllbiopro2018-09-05T09:39:44+09:009월 5th, 2018|
Job cuts among ‘tangible changes’ in Bayer’s R&D review: ReutersAllbiopro2018-09-05T09:39:11+09:009월 5th, 2018|
Sanofi diabetes VP jumps to NYC metabolic disease startup Applied TherapeuticsAllbiopro2018-09-05T09:38:08+09:009월 5th, 2018|
Former GSK cancer scientist admits attempt to steal trade secretsAllbiopro2018-09-05T09:37:34+09:009월 5th, 2018|
Redmile, GV power exosome specialist Evox to £36M roundAllbiopro2018-09-05T09:37:02+09:009월 5th, 2018|
Abivax posts ulcerative colitis data, commits to phase 2bAllbiopro2018-09-05T09:36:28+09:009월 5th, 2018|
False biosimilar communications: Originators rebuff Pfizer’s claimsAllbiopro2018-09-05T09:35:22+09:009월 5th, 2018|
Sartorius Stedim Biotech and Repligen Corporation Partner to Introduce Perfusion-Enabled BioreactorsAllbiopro2018-09-05T09:34:37+09:009월 5th, 2018|
Enzymicals extend its capacity in Business DevelopmentAllbiopro2018-09-05T09:32:41+09:009월 5th, 2018|
Parkinson’s disease: An endogenous protein might become a candidate for drug developmentAllbiopro2018-09-05T09:30:31+09:009월 5th, 2018|
Cablivi™ (caplacizumab) approved in Europe for adults with acquired thrombotic thrombocytopenic purpura (aTTP)Allbiopro2018-09-04T10:28:31+09:009월 4th, 2018|
